NCT07486960 Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015) Status RECRUITING Phase PHASE2
NCT07176390 A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014) Status RECRUITING Phase PHASE2
NCT07133633 A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013) Status RECRUITING Phase PHASE2
NCT06956235 Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06829225 Single Dose Study of Tulisokibart (MK-7240) in Healthy Chinese Participants (MK-7240-002) Status COMPLETED Phase PHASE1
NCT06651281 Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011) Status RECRUITING Phase PHASE3
NCT06575595 Pharmacokinetic (PK) Characterization of Subcutaneous Tulisokibart (MK-7240-010) Status COMPLETED Phase PHASE1
NCT05270668 Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05013905 A Phase 2a Safety and Efficacy Open-Label Study of Tulisokibart (MK-7240/PRA023) in Participants With Moderately to Severely Active Crohn's Disease (MK-7240-006) Status COMPLETED Phase PHASE2
NCT04996797 A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005) Status COMPLETED Phase PHASE2